IRIS
RAVAGLIA, SABRINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.096
EU - Europa 1.654
AS - Asia 1.486
SA - Sud America 154
AF - Africa 16
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.059
CN - Cina 822
IE - Irlanda 372
SG - Singapore 337
IT - Italia 284
DE - Germania 217
HK - Hong Kong 202
FI - Finlandia 200
RU - Federazione Russa 187
UA - Ucraina 170
BR - Brasile 124
GB - Regno Unito 80
VN - Vietnam 51
SE - Svezia 35
FR - Francia 26
CA - Canada 23
BE - Belgio 17
JP - Giappone 14
PL - Polonia 14
IN - India 13
AR - Argentina 12
BD - Bangladesh 11
NL - Olanda 10
MX - Messico 9
EC - Ecuador 7
ES - Italia 7
AT - Austria 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
CH - Svizzera 4
CL - Cile 4
ID - Indonesia 4
KR - Corea 4
PK - Pakistan 4
LT - Lituania 3
LU - Lussemburgo 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
DZ - Algeria 2
GR - Grecia 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TR - Turchia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.410
Salva come PNG Salva come JPEG
Città #
Chandler 376
Dublin 369
Dallas 219
Jacksonville 206
Hong Kong 202
Singapore 188
Ashburn 179
Beijing 179
Nanjing 164
Boardman 117
Helsinki 78
Munich 73
Los Angeles 66
Milan 66
Nanchang 60
Ann Arbor 52
Jiaxing 52
Pavia 52
Changsha 50
Lawrence 50
Princeton 50
Medford 49
Hebei 48
Shenyang 41
Wilmington 41
New York 40
Shanghai 34
Buffalo 33
Hangzhou 32
Turku 30
Moscow 28
Tianjin 21
Ho Chi Minh City 18
Brussels 17
Redondo Beach 16
Tokyo 14
Trieste 14
Verona 14
Toronto 13
Warsaw 13
Bergamo 12
Frankfurt am Main 12
Hanoi 11
São Paulo 11
Seattle 10
The Dalles 10
Turin 10
Woodbridge 10
Brooklyn 9
London 9
San Francisco 9
Atlanta 8
Cagliari 7
Chicago 7
Falkenstein 7
Montreal 7
Pune 7
Charlotte 6
Denver 6
Dhaka 6
Gorlago 6
Houston 6
Kunming 6
Lodi 6
Modena 6
Norwalk 6
Rome 6
Santa Clara 6
Stockholm 6
Amsterdam 5
Bologna 5
Boston 5
Brno 5
Columbus 5
Fairfield 5
Florence 5
Johannesburg 5
Mexico City 5
Monza 5
Piscataway 5
Poplar 5
Travaco Siccomario 5
Zhengzhou 5
Belo Horizonte 4
Como 4
Dresden 4
Hanover 4
Naples 4
Nuremberg 4
Washington 4
Auburn Hills 3
Biên Hòa 3
Buccinasco 3
Cork 3
Guarulhos 3
Manchester 3
Orem 3
Saluzzo 3
Udine 3
Athens 2
Totale 3.719
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 272
A first update on mapping the human genetic architecture of COVID-19 161
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. 139
Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) 119
Dietary treatment in adult-onset type II glycogenosis. 118
Cognitive impairment and central motor conduction time in chronic alcoholics. 113
Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. 113
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 106
Aspetti clinici e patogenetici della comorbidita’ emicranica. 103
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 101
Severe recurrent myelitis in patients with hepatitis C virus infection 99
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 99
Clinical MRI dissociation in myelopathy: a clue to sarcoidosis? 99
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 97
Genotype-phenotype correlation in Pompe disease, a step forward. 97
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 96
Early-onset ptosis in type II glycogenosis 95
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 93
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 92
Severe recurrent myelitis in patients with hepatitis C virus infection patients 91
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 90
Emicrania emiplegica familiare: dalla genetica alla clinica. 89
Guillain-Barré syndrome associated with SARS-CoV-2 89
Pathogenetic role of myelitis for syringomyelia. 88
Strabismo parossistico: Meccanismi corticali e meccanismi periferici nella fisiopatologia di due casi con analoga fenomenologia critica 88
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II 88
Triggering migraine attacks:the role of nitroderivatives. 88
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD) 87
Combined central and peripheral demyelination: comparison of adult and pediatric series 87
Efficacy of propafenone in paramyotonia congenita 86
Outcome after Two Years of Enzyme Replacement Therapy (ERT) in 29 Patients with Late-Onset Type II Glycogenosis (GSDII) 85
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up 83
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patientswith Alzheimer's disease and vascular dementia. 83
NMO-IgG-negative relapsing myelitis 82
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 82
Recombinant alglucosidase alpha (rhGAA) in adult-onset type II glycogenosis (GSDII): A follow-up study before and after treatment 81
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 79
Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis? 79
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 79
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 78
Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. 78
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 77
RECOMBINANT ALGLUCOSIDASE ALFA IN ADULT-ONSET GLYCOGENOSIS TYPE II: A FOLLOW-UP STUDY BEFORE AND AFTER TREATMENT 77
Presyrinx in children with Chiari malformations 76
Enzyme replacement therapy in adult-onset type II glycogenosis 73
Retinal migraine as unusual feature of cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) 72
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 69
Enzyme replacement therapy in late-onset type II glycogenosis. 64
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. 64
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 63
ENZYME REPLACEMENT THERAPY IN LATE-ONSET PHENOTYPES OF GLYCOGENOSIS TYPE 2: RESULTS OF AN ITALIAN MULTICENTER STUDY 62
Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression 62
The diagnosis of migraine: clinical and instrumental aspects 61
Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients 60
Erectile dysfunction as a sentinel symptom ofcardiovascular autonomic neuropathy in heavy drinkers 58
Post-infectious inflammatory disordes:sub-groups based on prospective follow-up. 57
Severe steroid-resistant post-infectious encephalomyelitis: General features and effects of IVIg 57
Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2 57
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 56
Post-infectious and postvaccinal acute disseminated encephalomyelitis occurring in the same patients 55
Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? 48
Enzyme replacement therapy with Alglucosidase alfa in juvenile-adult glycogenosis type 2 patients 44
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 38
null 34
Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study 19
Totale 5.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.301
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 0 39 2 44 6 40 36 7
2021/2022221 5 3 4 3 0 4 3 11 11 2 36 139
2022/20231.202 84 90 12 174 97 123 2 61 438 13 96 12
2023/2024398 49 73 11 18 28 102 5 26 5 10 19 52
2024/20251.113 34 96 60 31 35 74 68 51 248 42 105 269
2025/20261.202 209 203 260 220 286 24 0 0 0 0 0 0
Totale 5.475